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Editorial on the Research Topic
Molecular Chaperones and Neurodegeneration
Molecular chaperones, including heat-shock proteins (HSPs), or stress proteins, are highly
conserved proteins that play a critical role in the regulation of cellular protein homeostasis
(proteostasis). Proteostasis is essential for the maintenance of the functionality of the proteome
and, ultimately, of cells. Disruption of proteostasis leads to the accumulation of aberrantly folded
proteins that typically lose their function. The accumulation of misfolded and aggregated proteins,
due to genetic mutations, posttranslational modifications, or due to an age-related decline in
cellular functions, can be also cytotoxic and has been linked to the pathogenesis of various
degenerative diseases including those affecting the nervous system, such as Alzheimer’s (AD),
Parkinson’s (PD) and Huntington’s diseases (HD), or amyotrophic lateral sclerosis (ALS).
In addition to essential roles in de novo protein folding and the refolding of misfolded
proteins, molecular chaperones are functionally diverse and participate in a myriad of cellular
processes. These functions include preventing or resolving protein aggregation, and regulating
proteostasis through fundamental processes such as the unfolded protein response (UPR), the
heat shock response (HSR), chaperone-mediated autophagy (CMA), and the ubiquitin-proteasome
system (UPS). Chaperones are important components of multiple cellular networks, as they form
functional complexes with each other, with numerous co-chaperones regulating their function,
and with hundreds of other cellular proteins. Therefore, they promote the crosstalk between
various signaling pathways and regulate transcriptional networks. Finally, certain stress proteins
display diverse roles in immunity. Given their ubiquitous cellular roles, the potentially common
mechanisms of action that may apply, and the widespread consequences of their dysfunction,
there is great interest in understanding how molecular chaperones function and how they may
be manipulated to prevent or resolve protein aggregation linked to degenerative diseases, and
particularly, in neurodegenerative disorders.
In this special issue, we have gathered 14 articles covering novel and significant aspects about
the connection between chaperones and neurodegeneration, providing a series of updated and
insightful views of the mechanisms and functions of a wide variety of molecular chaperones in the
context of health and disease. Furthermore, this compilation offers a comprehensive overview of the
most recent findings, advances, and implications as putative targets for therapeutic intervention.
More specifically, we have arranged this special issue into three broad subjects, as follows: (A)
General mechanisms of molecular chaperones in the maintenance of cellular proteostasis in health
and disease; (B) Heat-shock proteins in aging, amyloid disease and cancer; (C) Functions and
mechanisms of molecular chaperones within the nervous system.
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A. GENERAL MECHANISMS OF
MOLECULAR CHAPERONES IN THE
MAINTENANCE OF CELLULAR
PROTEOSTASIS IN HEALTH AND DISEASE
Ciechanover and Kwon provide an updated general overview
of the protein quality control mechanisms in the cell, with
a focus on HSP functions in refolding and degradation of
terminally misfolded proteins. Their review carefully covers
the main protein degradation mechanisms, including the
UPS, macroautophagy, and CMA. They also analyse our
current understanding of the protective roles of chaperones
and recent therapeutic studies in various neurodegenerative
diseases. Lackie et al. focus on the HSP70/HSP90 HSPs, their
structures, molecular mechanisms, and their cellular functions
in combination with other chaperones, co-chaperones, and other
protein partners, including the FKBP family members, the PPIase
Cyp40, p23, and CHIP. Special attention is paid to the HSP90
co-chaperone Sti/Hop and its multiple roles in HSP90/HSP70-
mediated functions in modulating protein misfolding, followed
by an update on the main players and mechanisms of the
chaperone machinery in the context of the synucleinopathies,
HD, ALS, prion disease, and AD. On the other hand, Dubnikov
and Cohen provide an insightful review on the emerging
links between failure in early protein folding and maturation
of secreted proteins and the development of neurodegerative
disorders. They carefully analyse the early maturation events and
the quality control mechanisms for terminally misfolded proteins
within the ER, including ER-associated degradation (ERAD), the
unfolded protein response (UPR), the formation of aggresomes,
and other types of protein deposition sites, and their emerging
association with neurodegenerative disease. Finally, Jackrel and
Shorter describe our current knowledge and recent discoveries of
molecular chaperones as protein-remodeling factors, to prevent
or even reverse, protein aggregation processes in metazoans.
In particular, they give a detailed overview of the recently
characterized HSP110/HSP70/HSP40 disaggregase system, the
NMNAT2 NAD-synthesizing enzyme, and the HtrA1 serine
protease, from recent studies with misfolding disease models,
while evaluating the therapeutic potential of yeast Hsp104
disaggregase for treating human misfolding diseases.
B. HEAT-SHOCK PROTEINS IN THE
CONTEXT OF AGING, AMYLOID DISEASE
AND CANCER
The review by Stroo et al. provides a comprehensive account
of our current understanding of amyloid aggregates formation
and its cellular regulators in health, disease and aging, including
chaperone “disaggregases,” the role of chaperones in the main
protein degradation pathways (UPS, macroautophagy, CMA),
UPR, and protein compartmentalization. It also focuses on
key aspects linking amyloidogenesis and neurodegeneration,
such as amyloid formation modulators, the dysregulation
of protein homeostasis processes, and the mechanisms of
amyloid toxicity in neurodegenerative disease. The mini-review
by Kuiper et al. focuses on polyglutamine (polyQ) protein
aggregation associated to certain neurodegenerative disorders
such as HD, as well as on the various factors affecting the
aggregation process, particularly binding partners and molecular
chaperones, e.g., CHIP and members of the DnaJ family. In
addition to analyzing the multifactorial and complex nature of
the process leading to disease initiation, the authors discuss
the possibility that proper assessment of the different factors
could help predict the age of onset of disease. Buxbaum
and Johansson discuss the puzzling anti-amyloid activity of
amyloidogenic transthyretin (TTR) protein and the BRICHOS
domain on the AD-linked Aβ peptide, with a structural and
mechanistic focus. The review also analyses the emerging
links between TTR and BRICHOS-containing proteins and
disease through amyloid formation, and also discusses potential
therapeutic avenues for these amyloid precursors based on
their anti-Aβ oligomerization properties. The review by Casas
is a comprehensive and updated characterization of the ER
stress-related chaperone GRP78 (also known as Bip), its
multiple intracellular locations, interacting partners, and newly
discovered functions including its key participation in ERAD,
macroautophagy and the UPR. Furthermore, the author also
elaborates a comparative analysis between the roles of Bip/GRP78
in tumor cytoprotection and neuroprotection in the context of
neurodegenerative disease and aging. Finally, Calderwood and
Murshid analyse the exacerbation or decline of HSP expression
levels in cancer and AD, in the context of disease pathogenesis.
In addition, their review provides an updated overview of the
regulation mechanisms of the heat-shock response by HSF1
transcription factor, the key effector of HSP expression. The
authors further discuss the emerging evidence of the HSF1-based
dysregulation that might contribute to explain the intriguing
negative epidemiologic correlation observed between cancer
and AD.
C. FUNCTIONS AND MECHANISMS OF
MOLECULAR CHAPERONES WITHIN THE
NERVOUS SYSTEM
López-Ortega et al. report that long-term moderate reduction
of the essential co-chaperone, cysteine string protein
(CSPα/DnaJC5), reduces neuromusclar function. CSPα is
essential for synapse maintenance and severe functional and
structural changes occur in its absence. Through careful and
detailed analysis, they demonstrate that 1 year old CSPα
heterozygous mice, previously considered to be phenotypically
normal, have impairment in neuromuscular function. Their
findings imply that challenges lie ahead in identifying reduced
levels of chaperones (like CSPα) that lead to mild synaptic
impairment in patients. Gorenberg and Chandra provide an
insightful review of four main players in synaptic proteostasis:
CSPα/DnaJC5, auxilin/DnaJC6, RME-8/DnaJC13, and HSP110.
Their review covers the unique features of proteostasis at
the synapse highlighting both the current knowledge and
current questions. Special attention is paid to the HSP110
disaggregase system and mutations in synaptic chaperones
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that cause human neurodegenerative diseases. On the other
hand, Deane and Brown provide new information on HSPA6,
a member of the HSPA chaperone family that is induced
in neurons following heat shock. They carefully document
the unique induction and localization of neural HSPA6 in
comparison to two other HSPA family members, HSPA1A
and HSP8. Given this differential targeting, they highlight
the possible role of HSPA6 in human neurodegenerative
disorders, emphasizing that while HSPA6 is present in the
human genome it is absent from current mouse and rat models
of neurodegenerative disease thereby creating a gap in our
current understanding of HSPA6 function. Jung et al. provide an
insightful review on the links between neurodegeneration and
endoplasmic reticulum lipidostasis, proteostasis and calcium
homeostasis. Special attention is paid to the role of calnexin,
PDDIA3, BiP/GRP78 and cholesterol in the pathological
sequence of events underlying neurodegeneration. Finally,
Ousman et al. review the current knowledge of molecular
chaperones following nerve injury, focusing on neuron
survival, myelination, neuropathic pain, axon regeneration,
and inflammation. They address how changes in molecular
chaperone expression play an active role in injury or repair
processes and highlight the therapeutic challenges involved
in harnessing the beneficial properties while reducing the
injurious functions of chaperones to enhance CNS and PNS
recovery.
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